Bajos niveles de actividad de la lipasa ácida lisosomal y su relación con el desarrollo de la cirrosis de origen criptogénica/NASH: un estudio de cohorte
Luis Guillermo Toro Rendón, Luisa Fernanda Calle Tavera, Elizabeth Gutiérrez, Adriana Ocampo Mesa, J. Arbeláez
{"title":"Bajos niveles de actividad de la lipasa ácida lisosomal y su relación con el desarrollo de la cirrosis de origen criptogénica/NASH: un estudio de cohorte","authors":"Luis Guillermo Toro Rendón, Luisa Fernanda Calle Tavera, Elizabeth Gutiérrez, Adriana Ocampo Mesa, J. Arbeláez","doi":"10.52787/ZHJU9301","DOIUrl":null,"url":null,"abstract":"Introduction and objective. The deficiency of the Lysosomal acid lipase (LAL) activity has been related to cirrhosis due to non-alcoholic steatohepatitis (NASH). Many of the cirrhosis classified as cryptogenic are the evolution of liver disease due to fatty liver. The objective of the present study was to evaluate the lysosomal acid lipase (LAL) activity in the patients with liver cirrhosis of any etiology and establish whether low levels correlate with cryptogenic cirrhosis of origin cryptogenic or NASH. Methods. Was an analytical cohort study including 96 patients with cirrhosis of any etiology for which LAL activity was measured. Results. Fifty-five patients (58%) with cryptogenic cirrhosis or NASH were included and 41 with other etiologies. The fifty-three percent of the total population were women. The severity scores of liver disease were significantly higher in the patients with the cryptogenic cirrhosis or NASH: MELD (11.72 ± 7.3 vs 4,34 ± 5.7; p = 0.001) and Child-Pugh (7.26 ± 3.8 vs 7.26 ± 3.8; p = 0.004). LAL activity was significant lower (202.40 ± 98.8 vs 242.55 ± 121.9; p = 0.04) in the cirrhosis cryptogenic or NASH group. In the multivariate analysis, low LAL activity (< 150 nmol/spot/hour), was correlated with the presence of cryptogenic cirrhosis or NASH. Conclusions. The patients with cryptogenic cirrhosis or NASH have lower levels of LAL activity than those with cirrhosis of other etiologies. LAL activity below 150 nmol/spot/hour is predictive of the cryptogenic cirrhosis or NASH.","PeriodicalId":35700,"journal":{"name":"Acta Gastroenterologica Latinoamericana","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-03-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Gastroenterologica Latinoamericana","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.52787/ZHJU9301","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction and objective. The deficiency of the Lysosomal acid lipase (LAL) activity has been related to cirrhosis due to non-alcoholic steatohepatitis (NASH). Many of the cirrhosis classified as cryptogenic are the evolution of liver disease due to fatty liver. The objective of the present study was to evaluate the lysosomal acid lipase (LAL) activity in the patients with liver cirrhosis of any etiology and establish whether low levels correlate with cryptogenic cirrhosis of origin cryptogenic or NASH. Methods. Was an analytical cohort study including 96 patients with cirrhosis of any etiology for which LAL activity was measured. Results. Fifty-five patients (58%) with cryptogenic cirrhosis or NASH were included and 41 with other etiologies. The fifty-three percent of the total population were women. The severity scores of liver disease were significantly higher in the patients with the cryptogenic cirrhosis or NASH: MELD (11.72 ± 7.3 vs 4,34 ± 5.7; p = 0.001) and Child-Pugh (7.26 ± 3.8 vs 7.26 ± 3.8; p = 0.004). LAL activity was significant lower (202.40 ± 98.8 vs 242.55 ± 121.9; p = 0.04) in the cirrhosis cryptogenic or NASH group. In the multivariate analysis, low LAL activity (< 150 nmol/spot/hour), was correlated with the presence of cryptogenic cirrhosis or NASH. Conclusions. The patients with cryptogenic cirrhosis or NASH have lower levels of LAL activity than those with cirrhosis of other etiologies. LAL activity below 150 nmol/spot/hour is predictive of the cryptogenic cirrhosis or NASH.
引言和目标。溶酶体酸性脂肪酶(LAL)活性的缺乏与非酒精性脂肪性肝炎(NASH)引起的肝硬化有关。许多被归类为隐性肝硬化的肝硬化是由脂肪肝引起的肝病的演变。本研究的目的是评估任何病因的肝硬化患者的溶酶体酸性脂肪酶(LAL)活性,并确定低水平是否与来源于隐性或NASH的隐性肝硬化相关。方法。是一项分析性队列研究,包括96名任何病因的肝硬化患者,对其LAL活性进行了测量。后果包括55名(58%)隐源性肝硬化或NASH患者和41名其他病因患者。妇女占总人口的53%。隐源性肝硬化或NASH患者的肝脏疾病严重程度评分显著较高:MELD(11.72±7.3 vs 4,34±5.7;p=0.001)和Child-Pugh(7.26±3.8 vs 7.26±38;p=0.004)。肝硬化隐源性或NASH组的LAL活性显著较低(202.40±98.8 vs 242.55±121.9;p=0.04)。在多变量分析中,低LAL活性(<150 nmol/点/小时)与隐性肝硬化或NASH的存在相关。结论。隐源性肝硬化或NASH患者的LAL活性水平低于其他病因的肝硬化患者。LAL活性低于150nmol/spot/hour可预测隐性肝硬化或NASH。
期刊介绍:
Está dedicada a la investigación clínica y básica sobre todos los aspectos del aparato digestivo, incluídos el hígado, el páncreas y la nutrición, en seres humanos adultos y niños, animales de experimentación o sistemas celulares.